We are live on ! Find out more
IBO icon

Impact BioMedical

20 hedge funds and large institutions have $2.23M invested in Impact BioMedical in 2026 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,476% more capital inflows, than outflows

Capital inflows: $1.65M | Capital outflows: $105K

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

18.73% more ownership

Funds ownership: 11.82% → 30.55% (+19%)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

5% less funds holding

Funds holding: 21 → 20 (-1)

Holders
20
Holders Change
-1
Holders Change %
-4.76%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
5
Reduced
1
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

IBO Hedge Fund Activity: Q1 2026 in Review

20 of the 8,240 institutional investors tracked by Wall St. Rank reported a position in Impact BioMedical (IBO) for Q1 2026, worth a combined $2.23M — up 208% from $726K a quarter earlier.

Fund positioning in IBO was balanced in Q1 2026: 7 funds opened new positions, 7 closed out, 5 added to existing stakes and 1 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $559K. The largest seller was Millennium Management, exiting entirely with an estimated $69.6K sold.

  • 20 institutional investors held Impact BioMedical (IBO) as of Q1 2026, down from 21 in Q4 2025.
  • Funds reported $2.23M of Impact BioMedical stock for Q1 2026, up 208% quarter-over-quarter.
  • 7 funds opened new Impact BioMedical positions in Q1 2026 and 7 closed out, a net change of 0 holders.
  • The largest Impact BioMedical buyer in Q1 2026 was Geode Capital Management, an estimated $559K added.
  • The largest Impact BioMedical seller in Q1 2026 was Millennium Management, an estimated $69.6K sold.

Based on aggregated 13F filings for Q1 2026.